Description:

SOUTHWEST ONCOLOGY GROUP TREATMENT SUMMARY FORM (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3227788-83F0-2769-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3227788-83F0-2769-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00075764 Treatment - SOUTHWEST ONCOLOGY GROUP TREATMENT SUMMARY FORM (S0226) - 2174161v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP TREATMENT SUMMARY FORM (S0226)
    1. No Instruction available.
Header
Status
Vital Status
Has the patient progressed per the definition in Section 10.0 of the protocol? (Submit Follow-up Form and Follow-up Tumor Assessment Form)
Which treatment did the patient receive?
Were there any dose modifications or additions/omissions to protocol treatment since last form?
Did the patient receive fulvestrant this cycle? (Arm 2 only)
Did the patient receive fulvestrant this cycle? (Arm 2 only)
Ccrr Module For Southwest Oncology Group Treatment Summary Form (s0226)

Similar models